Myomo (MYO) Shareholder's Equity (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.03% |
| Sep 30, 2025 | -16.97% |
| Jun 30, 2025 | -18.78% |
| Mar 31, 2025 | -12.25% |
| Dec 31, 2024 | 165.96% |
| Sep 30, 2024 | -3.98% |
| Jun 30, 2024 | -11.21% |
| Mar 31, 2024 | 21.25% |
| Dec 31, 2023 | -18.45% |
| Sep 30, 2023 | 24.98% |
| Jun 30, 2023 | -8.43% |
| Mar 31, 2023 | 51.46% |
| Dec 31, 2022 | -18.70% |
| Sep 30, 2022 | -24.41% |
| Jun 30, 2022 | -19.60% |
| Mar 31, 2022 | -16.48% |
| Dec 31, 2021 | 17.20% |
| Sep 30, 2021 | -4.81% |
| Jun 30, 2021 | -14.04% |
| Mar 31, 2021 | 38.92% |
| Dec 31, 2020 | -10.92% |
| Sep 30, 2020 | 29.14% |
| Jun 30, 2020 | -14.68% |
| Mar 31, 2020 | 83.36% |
| Dec 31, 2019 | 45.43% |
| Sep 30, 2019 | -37.43% |
| Jun 30, 2019 | -25.17% |
| Mar 31, 2019 | 46.85% |
| Dec 31, 2018 | -28.19% |
| Sep 30, 2018 | -21.85% |
| Jun 30, 2018 | -17.76% |
| Mar 31, 2018 | 11.88% |
| Dec 31, 2017 | 383.26% |
| Sep 30, 2017 | -34.34% |